Sprinklr Announces Fourth Quarter and Full Year Fiscal 2023 Results
Go back to Sprinklr Announces Fourth Quarter and Full Year Fiscal 2023 Results| Cardium Therapeutics, Inc. (NYSE: CXM) | Delayed: 5.55 -0.36 (6.09%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.91 | 52 Week High | $1.44 | |||
| Open | $5.82 | 52 Week Low | $0.06 | |||
| Day High | $5.82 | P/E | N/A | |||
| Day Low | $5.50 | EPS | $-1.24 | |||
| Volume | 4,589,136 | |||||
